News | May 2022

T2 Insulin Insights Data Service

Now is the time to better understand those living with type 2 on insulin: a population that accounts for roughly 20% of the total diabetes population, and is the largest consumer of diabetes therapeutic products. Adoption of CGM and connected devices is growing fast, and changing patient experiences and expectations. Because patient involvement is critical to the success of treatments, rich data from authentic patients is crucial to address shortcomings and opportunities in how therapies perform.

dQ&A – T2 Insulin Insights is a unique semi-annual Research Service that unravels the complexities of the lived experience for people with type 2 diabetes who take insulin. Based on in-depth research with thousands of patients and over a decade of trended data, T2 Insulin Insights delivers pivotal research to answer key business questions.

Unlock the next frontier in diabetes. Contact us now to learn how.

About dQ&A – The Diabetes Research Company

dQ&A is a social enterprise committed to making life better for people with diabetes. We harness patient voices to drive better business results and better health outcomes. For over 14 years, we have been comprehensively tracking the diabetes experience in the United States, Canada, and Europe. We are trusted by diabetes industry leaders for our independence, commitment, and expertise. Our team has decades of experience in quantitative and qualitative research with a deep knowledge of diabetes. We’re efficient and effective; our insights are actionable and accessible. To learn more, send us an email at For research highlights, visit us at and follow us on LinkedIn (dQ&A – The Diabetes Research Company)